One of the key goals of Pharmacogenomics is to reduce adverse drug reactions (ADRs). ADRs are a significant problem in medicine and can occur for a variety of reasons, such as drug interactions, allergies, or improper dosing. By identifying genetic variations that affect how an individual responds to a medication, healthcare professionals can prescribe the right medication at the right dose, reducing the risk of ADRs.
Pharmacogenomics has numerous applications across medicine, including oncology, psychiatry, and cardiology. In oncology, pharmacogenomics can help predict an individual's response to cancer treatments, allowing healthcare professionals to tailor treatment plans to the individual. In psychiatry, pharmacogenomics can help predict an individual's response to antidepressants, antipsychotics, and other psychiatric medications. In cardiology, pharmacogenomics can help predict an individual's response to blood thinners and other cardiovascular medications.
Discover More- http://latestcmiblogs.weebly.com/article/pharmacogenomics-has-the-potential-to-transform-medicine-and-improve-patient-outcomes
